e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Pharmacological treatment in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Intractable breathlessness in COPD – A suitable case for palliation
H. Booth, C. Shipman, H. Thornton, S. Georgopoulou, A. Rivera, P. White (Cambridge, United Kingdom)
Source:
Annual Congress 2010 - Pharmacological treatment in primary care
Session:
Pharmacological treatment in primary care
Session type:
Thematic Poster Session
Number:
861
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Booth, C. Shipman, H. Thornton, S. Georgopoulou, A. Rivera, P. White (Cambridge, United Kingdom). Intractable breathlessness in COPD – A suitable case for palliation. Eur Respir J 2010; 36: Suppl. 54, 861
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Risk factors of adverse outcome after acute hospitalization in Idiopathic Pulmonary Fibrosis (IPF)
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Intractable breathlessness in COPD – A suitable case for palliation?
Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Year: 2011
Heliox administration in patients with COPD exacerbation – Technical aspects
Source: Annual Congress 2010 - Mechanical ventilation and weaning
Year: 2010
Chronic airflow obstruction in cases of new confirmed cavitary tuberculosis – Unrecognized COPD or disease manifestation?
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010
Halotherapy – A possible method to enhance airway treatment on patients with obstructive pathology
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Lung volume reduction surgery for a decompensated COPD – Case report
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011
Living with chronic obstructive pulmonary disease (COPD) – A lifeworld perspective
Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease
Year: 2010
Management of refractory dyspnoea in COPD
Source: Virtual Congress 2021 – Highlights from the JAMA Network on idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease and lung cancer screening
Year: 2021
Pulmonary rehabilitation in patients with interstitial lung disease – An useful therapeutic option?
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011
Symptoms and examination findings in patients with bronchiectasis – Signs of hyperinflation may be under-appreciated
Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach
Year: 2010
Chronic non-asthmatic cough – Are we nearer to define the airway pathology?
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Symptoms experienced by COPD patients during exacerbations and their association with healthcare utilization – EXACO study
Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics
Year: 2011
Eosinophilic pneumonia – Our own experience with diagnosis and treatment
Source: Annual Congress 2012 - The good clinical practice: useful case report
Year: 2012
Haemoptysis in children – some respiratory causes
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009
Respiratory muscle function during and after a severe exacerbation of COPD – Preliminary results
Source: Annual Congress 2011 - Respiratory physiotherapy in the intensive care unit and on the ward: breathing exercises and respiratory muscles
Year: 2011
Reduced exertional dyspnea with supplemental oxygen in patients with COPD – Characteristics of responders and non-responders
Source: Annual Congress 2012 - The best abstracts in chronic care
Year: 2012
Diagnosing COPD and asthma in primary care in Israel – The challenge and the change
Source: Annual Congress 2011 - Integrated care and telehealth in primary care
Year: 2011
Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Clinical prediction of sleep apnoea – a tool for the selection of patients
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
The journey to severe obstructive lung disease – Retrospective study of FEV1 decline
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
Respiratory bronchiolitis interstitial lung disease – What is the natural history?
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept